dianisidine has been researched along with Cerebral Pseudosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marano, M; Pasqualetti, P; Siotto, M; Squitti, R | 1 |
| Eisenbach, C; Merle, U; Stremmel, W; Tuma, S; Weiss, KH | 1 |
2 other study(ies) available for dianisidine and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson's disease and in hepatic encephalopathy.
Topics: Automation, Laboratory; Blood Chemical Analysis; Ceruloplasmin; Dianisidine; End Stage Liver Disease; Fasting; Hepatic Encephalopathy; Hepatolenticular Degeneration; Humans | 2014 |
Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease.
Topics: Adult; Biomarkers; Blood Chemical Analysis; Case-Control Studies; Ceruloplasmin; Dianisidine; Female; Hepatolenticular Degeneration; Humans; Immunoassay; Male; Middle Aged; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2009 |